{
    "2020-01-10": [
        [
            {
                "time": "",
                "original_text": "机构调研:5万亿航母战投1股原因曝光 睿远关注医药股",
                "features": {
                    "keywords": [
                        "机构调研",
                        "5万亿",
                        "航母战投",
                        "睿远",
                        "医药股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德：全资子公司拟300万英镑认购英国Epidarex投资基金份额",
                "features": {
                    "keywords": [
                        "药明康德",
                        "全资子公司",
                        "300万英镑",
                        "Epidarex",
                        "投资基金"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德(02359)认购私募基金Epidarex 300万英镑的份额",
                "features": {
                    "keywords": [
                        "药明康德",
                        "02359",
                        "私募基金",
                        "Epidarex",
                        "300万英镑"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德(603259)：去年被高瓴加持48亿，当下还能不能上车？",
                "features": {
                    "keywords": [
                        "药明康德",
                        "603259",
                        "高瓴",
                        "48亿",
                        "投资"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "CRO行业迎来黄金发展期，这些企业值得关注",
                "features": {
                    "keywords": [
                        "CRO行业",
                        "黄金发展期",
                        "企业"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}